Greetings from Edinburgh!
View this email in your browser

Trusted evidence. Informed decisions. Better health.

Issue 5 | Summer 2017

Read on for details on staff changes within the editorial base and publications since our last newsletter.  Visit our website to see all our reviews; as well as pages detailing guidelines citing our reviews and reviews that have been translated.


Firstly, we would like to offer our heartfelt thanks to Dr Karen Welch, who recently retired.  In her 14 years as Information Specialist (previously Trials Search Co-ordinator), she will, at some point, have developed and run searches for every protocol, review and update registered with us.  We are hugely grateful for her enormous and invaluable contributions - in so many ways - to Cochrane Vascular.
Secondly, we would like to introduce Candida Fenton, our new Information Specialist and Systematic Review Methodologist!  We welcome her to the editorial base and look forward to working with her.
Finally, over the last year, three of our Editors have stepped down from this role. We would like to offer a huge thanks to Mr Tim Lees, Mr Paul Bachoo and Professor Jos Kleijnen for all their advice and hard work over many years. Their valuable contributions are very much appreciated. 
The 2018 Cochrane Colloquium (15th to 18th of September 2018) will be held here in Edinburgh!  This presents an excellent opportunity for us to meet as many of our members as possible, so save the dates and look out for further information on Vascular specific events during the Colloquium.  If there are any event/workshop ideas you wish to suggest please get in touch.


MECIR (Methodological Expectations for Cochrane Intervention Reviews) are methodological standards which all Cochrane Protocols, Reviews, and Updates are expected to follow. They provide authors and users of the Cochrane Library with clear and transparent expectations of review conduct and reporting. New sets of standards to cover the reporting of protocols and the planning, conduct and reporting of updates have been added.  It is important to be aware of these and details can be found here.
Cochrane is moving away from focusing on whether a result is statistically significant or not.  This is to prevent instances where a lack of statistical significance is interpreted as no effect, or when too much importance is placed on a statistically significant but small difference in treatment effects.  Emphasis should instead be placed on the magnitude and precision of the estimated effect.  Please consider carefully how you describe your results.  One example is where a statistically non-significant difference may be most accurately reported as 'no clear difference was seen' or 'we are uncertain as to whether [intervention] has an important effect on [outcome] because the results are imprecise'.
Keep on top of changes in Cochrane policies by visiting our essential resource portal. If you are authoring a protocol we suggest you watch this very helpful webinar which discusses each section in turn and highlights common mistakes. New resources to help assess for GRADE and create your 'Summary of findings' table can be found here.  A revised edition of the Style Guide is also available now.

The 2016 Impact Factor for Cochrane Database of Systematic Reviews is 6.124, a slight increase from the 2015 Impact Factor.

See below for details of the nine updates, seven reviews (including two DTA reviews), and five protocols published since our last newsletter. Thank you for all the hard work by authors, editors and referees who have made this possible and to all those currently writing. 

Updated reviews

Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE
Lindsay Robertson, Su Ern Yeoh, Gerard Stansby, Roshan Agarwal

Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism
Alina Andras, Adriano Sala Tenna, Marlene Stewart

Endovascular treatment for ruptured abdominal aortic aneurysm
Stephen Badger, Rachel Forster, Paul H Blair, Peter Ellis, Frank Kee, Denis W Harkin

Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients
Daniela R Junqueira, Liliane M Zorzela, Edson Perini

Bypass surgery for chronic lower limb ischaemia
George A Antoniou, George S Georgiadis, Stavros A Antoniou, Ragai R Makar, Jonathan D Smout, Francesco Torella

Totally percutaneous versus surgical cut‐down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair
Madelaine Gimzewska, Alexander IR Jackson, Su Ern Yeoh, Mike Clarke

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Lindsay Robertson, James Strachan

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
Lindsay Robertson, Lauren E Jones

Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm
Lindsay Robertson, Edmond Atallah, Gerard Stansby

New reviews

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization
Aniek AG Zee, Kelly van Lieshout, Maaike van der Heide, Loes Janssen, Heinrich MJ Janzing

Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair (DTA)
Iosief Abraha, Maria Laura Luchetta, Rita De Florio, Francesco Cozzolino, Giovanni Casazza, Piergiorgio Duca, Basso Parente, Massimiliano Orso, Antonella Germani, Paolo Eusebi, Alessandro Montedori

Growth factors for angiogenesis in peripheral arterial disease
Vitali Gorenoi, Michael U Brehm, Armin Koch, Anja Hagen

Laparoscopic surgery for elective abdominal aortic aneurysm repair
Lindsay Robertson, Sandip Nandhra

Corticosteroids for the treatment of Kawasaki disease in children
Andrew J Wardle, Georgia M Connolly, Matthew J Seager, Robert MR Tulloh

Imaging for the exclusion of pulmonary embolism in pregnancy (DTA)
Thijs E van Mens, Luuk JJ Scheres, Paulien G de Jong, Mariska MG Leeflang, Mathilde

Lumbar sympathectomy techniques for critical lower limb ischaemia due to non‐reconstructable peripheral arterial disease
Veena KL Karanth, Tulasi Kota Karanth, Laxminarayan Karanth


Treatment for telangiectasias and reticular veins
Luis CU Nakano, Daniel G Cacione, Jose CC Baptista-Silva, Ronald LG Flumignan

Endoluminal stents for iliac and infrainguinal arterial disease
Andrew Walker, Kosmas I Paraskevas, Gerard Stansby, Peng F Wong

Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
Malgorzata M Bala, Elzbieta M Paszek, Dorota Wloch‐Kopec, Wiktoria Lesniak, Anetta Undas

Angioplasty and stenting for peripheral arterial disease of the lower limbs: an overview of Cochrane Reviews
Lindsay Robertson, Kosmas I Paraskevas, Marlene Stewart

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the femoropopliteal arteries
Ahmed Kayssi, Wissam Al‐Jundi, Giuseppe Papia, Daryl S Kucey, Thomas Forbes, Dheeraj K Rajan, Richard Neville, Andrew D Dueck

Editorial base

Co-ordinating Editors
Professor Jackie Price
Professor Gerry Stansby

Managing Editor
Dr Marlene Stewart

Information Specialist/Systematic Review Methodologist
Ms Candida Fenton

Assistant Managing Editor
Dr Cathryn Broderick

Mrs Evelyn Crooks
Mrs Elsbeth Hamilton

Feedback Editor Professor Julie Brittenden
Statistical Editor Professor Steff Lewis
Statistician Dr Catriona Keerie
Professor John Fletcher
Professor William Hiatt
Dr Stavros Kakkos
Mrs Heather Maxwell
Dr Saskia Middeldorp
Professor Greg Moneta
Professor Martin Prins
Mr Paul Tisi
Dr Stewart Walsh
Dr Lorna Watson

General enquires
Copyright © 2017 Cochrane Vascular, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp